NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
Medically reviewed on 11/16/2020 by
Dr. Geoffrey Grammer
Chief Medical Officer
Most people know that menopause is associated with physical symptoms like hot flashes, but there's a link between menopause and depression, too—one that's often under-recognized. During perimenopause—the years leading up to menopause—estrogen levels decrease. One study found that depression is 2.5 times more likely at this time of life than in the years before or after. However, perimenopausal depression is frequently missed, partly because physical symptoms receive more attention and partly because many depression symptoms overlap with those of menopause. Symptoms shared by both depression and menopause include low energy, changes in libido, trouble concentrating, sleep disturbances, and weight changes. The reassuring news is that treating the mental health symptoms of menopause can help with the physical ones, too. Taking a little time to understand the link between menopause and depression can be a meaningful first step along the road to better health.
Three broad factors link menopause and depression: hormones, sleep disturbances, and life stressors.
Hormone Changes. Hormonal fluctuations are an integral feature of perimenopause. During these years, people experience fluctuating and decreasing levels of estrogen. Estrogen plays a key role in the manufacture, efficiency, breakdown, and regulation of chemical messengers such as serotonin and norepinephrine. These chemical messengers (neurotransmitters) influence mood and behavior: Normal levels contribute to feelings of wellness, calm, happiness, and contentment. Decreased or fluctuating estrogen levels in perimenopause can disrupt the normal functioning of serotonin and norepinephrine in some women, which in turn can lead to depression.
Sleep Disturbances. Sleep disturbances are a notable symptom of depression, and perimenopause is similarly associated with sleep-related issues. A third of perimenopausal people report sleep difficulties, often related to uncomfortable night sweats, and those transitioning to menopause are up to 3.5 times more likely to report severe sleep difficulties than their premenopausal counterparts. This is likely related to a perimenopausal decline in certain hormones that influence sleep patterns—estrogen, progesterone, melatonin, and growth hormone. Other non-menopausal factors can also affect sleep in midlife, including chronic illness and a natural age-related change in our sleep patterns.
Life Stressors. Menopause frequently arrives at a time when people are already experiencing significant shifts in their lives (95 percent of people have their last period between the ages of 45 and 55). The following factors, often associated with midlife, are also associated with an increased risk of depression:
Although midlife can be a time of seismic change, it's also a time where some feel especially empowered to reach out for the treatment they deserve. Finding the right treatment choice for you is the next step.
Thanks for subscribing to our list!
Depression isn't something you simply have to accept in your perimenopausal years. Untreated perimenopausal depression exacerbates heart disease, diabetes, and osteoporosis, so it's important to seek depression treatment early. Talk therapy and medications help many people with depression. Selective serotonin reuptake inhibitors (SSRIs) can also relieve some of the physical symptoms of menopause, such as hot flashes and insomnia.
Menopausal hormone therapy can also soothe the physical symptoms of menopause (hot flashes, night sweats, and sleep disturbances). Some studies suggest that estrogen replacement therapy can help mood and enhance the effects of antidepressants. There are two caveats about the above drug-based treatments. First, hormone therapy may not be suitable for you if you are a smoker, have high blood pressure, or have a history of breast cancer, blood clots, or active liver disease due to increased risk of adverse effects. Second, up to a third of people with depression don't respond to antidepressants.
If you don't respond to antidepressant medications, there are non-drug options you can try, including Transcranial Magnetic Stimulation (TMS). TMS applies highly focused magnetic pulses to brain regions that are crucial in the regulation of mood. TMS is a non-invasive treatment that has been cleared by the FDA for the management of Major Depressive Disorder when one medication hasn't been effective (though typically covered by insurance after two). TMS can help to relieve some or even all of the symptoms of depression in many patients and is suitable for people with depression related to perimenopause. The symptoms of menopause have long been viewed as inevitable or inescapable. Thankfully, times have changed, and effective treatments are helping people with perimenopausal depression live the lives they deserve.
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.